CD4 and inflammatory bowel disease: Consistent with these concerns, Cook et al. demonstrated that IBD patients without recognized CDI can exhibit heightened circulating TcdB-specific CD4+ T-cell responses despite negative stool tcdB PCR, suggesting occult toxin exposure and supporting targeted testing when disease activity changes [31].